Sustainably released nanoparticle-based rhynchophylline limits pulmonary fibrosis by inhibiting the TEK-PI3K/AKT signaling pathway.

Shuo Wang,Zhanghao Huang,Yifei Liu,Hui Sun,Youlang Zhou,Jiahai Shi

Translational lung cancer research（2023）

引用 0|浏览1

暂无评分

摘要

Our findings indicate that Rhy constrained PF progression by inhibiting TEK-PI3K/AKT signaling pathway. Hence, this sustainable release system of Rhy is a highly effective therapy to limit PF and should be developed.

查看译文

关键词

PI3K/AKT,Pulmonary fibrosis (PF),TEK,nanoparticles,rhynchophylline

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要